HYPOMAGNESEMIA AND RENAL MAGNESIUM WASTING IN PATIENTS TREATED WITH CISPLATIN

被引：69

作者：

LAM, M

ADELSTEIN, DJ

机构：

[1] CLEVELAND METROPOLITAN GEN HOSP,DEPT,DIV ONCOL,CLEVELAND,OH 44109

[2] CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106

来源：

关键词：

D O I：

10.1016/S0272-6386(86)80020-8

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：164 / 169

页数：6

共 22 条

[1]

ANDERSON T, 1979, CANCER TREAT REP, V63, P1687

[2] RENAL AND ELECTROLYTE DISTURBANCES ASSOCIATED WITH CISPLATIN [J].

BLACHLEY, JD ;

HILL, JB .

[3] HYPOMAGNESEMIA AFTER CISPLATIN COMBINATION CHEMOTHERAPY [J].

BUCKLEY, JE ;

CLARK, VL ;

MEYER, TJ ;

PEARLMAN, NW .

[4]

CHARY K K, 1977, Journal of Clinical Hematology and Oncology, V7, P633

[5]

DENTINO M, 1978, CANCER, V41, P1274, DOI 10.1002/1097-0142(197804)41:4<1274::AID-CNCR2820410410>3.0.CO

[6]

2-F

[7]

FLINK EB, 1981, ACTA MED SCAND, P125

[8]

GOLDSTEIN MH, 1981, KIDNEY INT, V19, P201

[9]

GONZALEZ C, 1982, OBSTET GYNECOL, V59, P732

[10]

HAYES DM, 1977, CANCER, V39, P1372, DOI 10.1002/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO